FDA Approves First Therapy for Allergic Fungal Rhinosinusitis - Poll - MDSpire

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 2 min

Share

Original Source(s)

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

  • by Kathryn Wighton

  • February 25, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

Correction: Measuring mental wellbeing in clinical and non-clinical adolescents using the COMPAS-W Wellbeing Scale